Literature DB >> 32670738

Chemoprophylactic activity of nitazoxanide in experimental model of mammary gland carcinoma in rats.

Ajay Kumar Pal1, Mukesh Nandave1, Gaurav Kaithwas2.   

Abstract

The current study focuses on the evaluation of the chemoprophylactic activity of nitazoxanide against the mammary gland carcinoma in experimental rats. The experimental protocol involves total 50 female Wistar albino rats of body weight 120-150 g, which were randomly categorized into five groups; Normal control (1% w/v carboxymethyl cellulose, p.o.); Toxic control (N-methyl-N-nitrosourea, MNU, 47 mg/kg i.v.); Standard (MNU, 47 mg/kg i.v. + tamoxifen, 1 mg/kg p.o.); Treatment 1 (MNU, 47 mg/kg i.v. + NTZ low-dose, 25 mg/kg p.o.); and Treatment 2 (MNU, 47 mg/kg, i.v. + NTZ high-dose, 50 mg/kg p.o.). The mammary gland carcinoma was induced by a single tail vein intravenous injection of MNU at a 47 mg/kg dose. Seven days after MNU administration, daily dosing of nitazoxanide and tamoxifen was initiated till 110th day in respective groups. The MNU toxicity was apparent with the altered electrocardiogram and heart rate variability, increased number of alveolar bud count, differentiation score, and upregulated antioxidant parameters. Nitazoxanide treatment restored the histological architecture in rats along with the reduction of alveolar buds and downregulation of oxidative stress markers as well as inflammatory markers. Therefore, nitazoxanide can be utilized as a potential chemoprophylactic agent against mammary gland carcinoma induced by MNU. © King Abdulaziz City for Science and Technology 2020.

Entities:  

Keywords:  Breast cancer; Lymph node metastasis; Mammary gland carcinoma; N-methyl-N-nitrosourea; Nitazoxanide

Year:  2020        PMID: 32670738      PMCID: PMC7343672          DOI: 10.1007/s13205-020-02332-z

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  44 in total

1.  PHD-2 activation: a novel strategy to control HIF-1α and mitochondrial stress to modulate mammary gland pathophysiology in ER+ subtype.

Authors:  Uma Devi; Manjari Singh; Subhadeep Roy; Avinash C Tripathi; Pushpraj S Gupta; Shailendra K Saraf; Md Nazam Ansari; Abdulaziz S Saeedan; Gaurav Kaithwas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-06-01       Impact factor: 3.000

2.  Redefining the role of peripheral LPS as a neuroinflammatory agent and evaluating the role of hydrogen sulphide through metformin intervention.

Authors:  Virendra Tiwari; Manjari Singh; Jitendra K Rawat; Uma Devi; Rajnish K Yadav; Subhadeep Roy; Swetlana Gautam; Shubhini A Saraf; Vikas Kumar; Nazam Ansari; Abdulaziz S Saeedan; Gaurav Kaithwas
Journal:  Inflammopharmacology       Date:  2016-08-03       Impact factor: 4.473

3.  Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni.

Authors:  Paul S Hoffman; Gary Sisson; Matthew A Croxen; Kevin Welch; W Dean Harman; Nunilo Cremades; Michael G Morash
Journal:  Antimicrob Agents Chemother       Date:  2006-12-11       Impact factor: 5.191

4.  Activation of prolyl hydroxylase-2 for stabilization of mitochondrial stress along with simultaneous downregulation of HIF-1α/FASN in ER + breast cancer subtype.

Authors:  Uma Devi; Manjari Singh; Subhadeep Roy; Pushpraj S Gupta; Mohd Nazam Ansari; Abdulaziz S Saeedan; Gaurav Kaithwas
Journal:  Cell Biochem Funct       Date:  2019-04-05       Impact factor: 3.685

Review 5.  Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy.

Authors:  Mario Romano; Joan Claria
Journal:  FASEB J       Date:  2003-11       Impact factor: 5.191

6.  Nitazoxanide pharmacokinetics and tolerability in man during 7 days dosing with 0.5 g and 1 g b.i.d.

Authors:  A Stockis; S De Bruyn; C Gengler; D Rosillon
Journal:  Int J Clin Pharmacol Ther       Date:  2002-05       Impact factor: 1.366

7.  Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth.

Authors:  D Nie; G G Hillman; T Geddes; K Tang; C Pierson; D J Grignon; K V Honn
Journal:  Cancer Res       Date:  1998-09-15       Impact factor: 12.701

8.  Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori.

Authors:  Gary Sisson; Avery Goodwin; Ausra Raudonikiene; Nicky J Hughes; Asish K Mukhopadhyay; Douglas E Berg; Paul S Hoffman
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

9.  Revisiting the systemic lipopolysaccharide mediated neuroinflammation: Appraising the effect of l-cysteine mediated hydrogen sulphide on it.

Authors:  Abdulaziz S Al-Saeedan; Varsha Gautam; Mohd Nazam Ansari; Manjari Singh; Rajnish K Yadav; Jitendra K Rawat; Uma Devi; Swetlana Gautam; Subhadeep Roy; Gaurav Kaithwas
Journal:  Saudi Pharm J       Date:  2018-02-06       Impact factor: 4.330

10.  Transcutaneous Vagus Nerve Stimulation Regulates the Cholinergic Anti-inflammatory Pathway to Counteract 1, 2-Dimethylhydrazine Induced Colon Carcinogenesis in Albino wistar Rats.

Authors:  Jitendra K Rawat; Subhadeep Roy; Manjari Singh; Swetlana Guatam; Rajnish K Yadav; Mohd Nazam Ansari; Sara A Aldossary; Abdulaziz S Saeedan; Gaurav Kaithwas
Journal:  Front Pharmacol       Date:  2019-05-21       Impact factor: 5.810

View more
  2 in total

Review 1.  Targeting the Wnt signaling pathway for breast cancer bone metastasis therapy.

Authors:  Jingyao Cui; Haoran Chen; Kaiwen Zhang; Xin Li
Journal:  J Mol Med (Berl)       Date:  2021-11-25       Impact factor: 4.599

Review 2.  Protein Kinase R in Bacterial Infections: Friend or Foe?

Authors:  Robin Smyth; Jim Sun
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.